BindingDB logo
myBDB logout

null

SMILES: NC(=O)CS(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1

InChI Key: InChIKey=JOLDAOATYHKDBL-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 111134   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cannabinoid receptor 2


(Homo sapiens (Human))
BDBM111134
PNG
(US9682940, 25)
Show SMILES NC(=O)CS(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C27H26Cl2N4O3S/c28-21-6-1-17(2-7-21)26(18-3-8-22(29)9-4-18)20-5-10-24-23(15-20)27(32-31-24)19-11-13-33(14-12-19)37(35,36)16-25(30)34/h1-10,15,19,26H,11-14,16H2,(H2,30,34)(H,31,32)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+4n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...


US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair
Cannabinoid receptor 1


(Homo sapiens (Human))
BDBM111134
PNG
(US9682940, 25)
Show SMILES NC(=O)CS(=O)(=O)N1CCC(CC1)c1n[nH]c2ccc(cc12)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1
Show InChI InChI=1S/C27H26Cl2N4O3S/c28-21-6-1-17(2-7-21)26(18-3-8-22(29)9-4-18)20-5-10-24-23(15-20)27(32-31-24)19-11-13-33(14-12-19)37(35,36)16-25(30)34/h1-10,15,19,26H,11-14,16H2,(H2,30,34)(H,31,32)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1.23E+3n/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
CB1 and CB2 receptors are Gi-coupled GPCR. Activation of CB1 and CB2 receptors results in a decrease in cAMP production. An inverse agonist of the CB...


US Patent US9682940 (2017)


BindingDB Entry DOI: 10.7270/Q2M61HD7
More data for this
Ligand-Target Pair